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Abstract. This paper presents three distinct challenges to research and 
development (R&D) of marketable eHealth systems and suggests strategies to 
mitigate them. The eHealth system in question is designed to improve self-care 
and collaboration between remotely monitored heart failure patients and clinicians. 
By way of introspection and reflection on a current and a previous project, the 
authors propose solutions for mitigating the central challenges. 
Keywords. Methods, research and development, eHealth, regulatory requirements, 
mitigation 
Introduction 
Patient-centered eHealth is expected to improve health outcomes. For more than a 
decade it has been a cornerstone in eHealth research to engage patients in their own 
treatment and care. Many studies in Health Informatics and HCI show promising 
potentials of self-management and remote collaboration between clinicians and patients  
[1, 4, 6, 12]. Yet few prototypes leave the research lab to become marketable systems. 
Moreover, contradictory to the overly positive potentials, stands the evaluation of 
collaborative eHealth systems that are currently available and in use by patients and 
clinicians. A critical review of telemonitoring systems, for example, shows the lack of 
high quality evidence for improved outcomes or cost-effectiveness [7], while others 
reveal unintended consequences e.g. complicate the patient-physician relation [8, 9]. 
We address the multi-edged challenge in R&D of marketable eHealth that hold 
commercial value, support patient self-management, and improve remote collaboration 
between clinicians and patients. We describe challenges in running large-scale 
experiments, and at the same time, mobilizing a transition from research prototypes 
into a regulatory approved implementation process that ends with a marketable eHealth 
system. By introspection and critical reflection, we analyse the problems encountered 
in a previous project (CITH) and propose the mitigation strategies that we try out in a 
newly started project (SCAUT). We use the concept of ‘context’ to highlight the gaps 
that exist when moving between the contexts of design and use and between research- 
and commercially-oriented contexts. We have experienced three challenges in bridging 
these gaps due to only partly overlapping experiences, concerns, and rationales. 
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 1.  New Contexts: From CITH to SCAUT 
We are an interdisciplinary group of cardiologists, public health and computer 
scientists. In our prior work [ see 1, 2], we discuss challenges and opportunities as to 
features and affordances of eHealth systems to support self-care and collaboration 
between patients and clinicians. Instead, here we address methodological issues related 
to making the transition and move research and development (R&D) prototypes to a 
market that has high regulatory demands. We base our reflections and recommendation 
on two projects that deal with remotely monitored patients with implantable cardiac 
devices (ICDs and pacemakers). 
The purpose of the CITH-project (2008-13) was to explore the solution space and 
develop concepts and prototypes. In the SCAUT project (2014-18) we have teamed up 
with a software company and a medical device manufacturer to further explore the 
solution space and to transform prototypes into products. The combined purpose of 
SCAUT is to bring an eHealth system to the market, while still delivering traditional 
research in the form of papers and theses. The overall R&D approach is presented 
below. First, however, we describe how the contexts of the two projects are similar and 
how they differ. In section 2 we discuss the challenges induced by these differences 
and the mitigation strategies that we propose. 
1.1. Use Contexts 
Firstly, the use context is shared by the two projects, and it has three main elements: 
patients’ homes and two clinical settings. Patients and clinicians live and work in 
different contexts and they hold different views on disease, treatment and care [2, 5].  
The ways in which patients relate to their disease vary according to where they are in 
their trajectory. Partly therefore, they have developed a diverse set of strategies for 
handling the different types of information they collect or receive related to their 
disease, and they use different media for that purpose. In the two clinical settings 
decisions are taken whether or not to change the treatment. At the university hospital 
any alteration of the treatment is primarily based on interpretation of data from the 
cardiac device. However, at the local hospital or at the general practitioner’s office the 
patients overall situation and the medication are the main issues. 
1.2. Project Contexts 
Secondly, there are the project contexts, where the design, development and 
implementation take place and where the two projects are clearly different.  We strive 
for design, development and implementation to be more intertwined than indicated 
below, but for clarity we distinguish between three project contexts: (a) the IT-
researchers’ habitat that mainly includes patients’ homes, clinical settings, the 
university and the two companies; (b) the software company, which holds the primary 
responsibility for the development and implementation; and (c) the medical device 
manufacturer that employs its own R&D departments in the US and in Europe, and will 
licence the software, if we are successful.  
As also pointed out in Eng [15] there exist some tensions between academic 
institutions and commercial companies: researchers’ primarily strive to produce new 
knowledge, while companies are in the project to explore new market opportunities. 
However, SCAUT participants acknowledge, that both parties are critical for academic 
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 as well as commercial success.  
1.3. Overall R&D Approach for Both Projects 
The diverse use contexts motivate that we start out with ethnographic techniques to 
explore existing practices in patients’ homes and in clinics. We used prototyping to 
experiment with versions of a Personal Health Record and with a set of (re-)designed 
tools and services supporting the work of clinicians, patients, and relatives. Based on 
such experiments, we iteratively adjust the prototype, the tasks, and the roles, but we 
also learn about new issues in the current practices, which then inform the next round 
of design activities. Initially, the experiments are conducted in isolation from the daily 
practices, but as the prototype matures we intervene to cautiously try out the prototype, 
the tasks, and the roles as part of real life practices. This takes place within an overall 
participatory approach for users to have a say and to foster mutual learning [3]. 
Clinicians, patients and relatives participate actively in defining the aim of the project 
as well as in analyses, design, and evaluation. A final element in the methodological 
approach is theoretical reflections on the use of evolving prototypes based on medical 
phenomenology [5] and studies of other researchers [see e.g. 10, 11].  
2. Bringing Health Informatics to the Market: Three Challenges 
We have experienced three challenges in bridging the gaps between the contexts of 
design and use and between research- and commercially-oriented contexts. Below we 
argue that these challenges are rooted in the only partly overlapping experiences, 
concerns, and rationales of the researchers and industrial partners, who have joined 
forces for the purpose of developing a marketable eHealth system. An overview of the 
challenges, their potential consequences and suggested mitigation strategies are listed 
in table 1, and they are argued for below. 
 
Table 1. Overview of challenges, consequences and strategies for mitigations 
Challenge Potential Consequence Mitigation strategies 
Create an efficient R&D 
process 
Cumbersome coordinative work 
Scaling becomes unmanageable 
Increased overhead work 
R&D tool that supports: 
- recruting patients 
- communication with users 
- overview of (non-)use  
- easy to introduce new 
features to many users 
 
Integrate all stakeholders’ 
interests 
Losing commitment from key 
stakeholders 
 
Active user participation 
Business Model Canvas for 
pre-assessing the value pro-
positions of the prototypes  
Adjust The Stage Gate 
Model using Scrum 
 
Design within regulatory 
requirements 
Product will not be approved Treat regulatory issues as 
design parameters 
Integrate a regulatory 
process into the production 
process from the start 
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 2.1. The Challenge of Establishing an Efficient R&D Process 
The first challenge is to establish an efficient R&D process. In the CITH project, the 
R&D process progressed through three stages. As it turned out, the coordinative efforts 
intensified and overhead work related to preparing and setting up the experiments grew 
critically in the last stage where we tried out prototypes that connected people. For 
example, we developed and distributed information material and started to keep various 
spreadsheets and other documents with updated information on e.g. which version of 
the prototype patients were using, dates of healthcare appointments and notes on which 
researcher had been in contact with the patient, when and what they discussed. This 
was to ensure coordination among the researchers and to keep an overview of what was 
going on in terms of patient participation. We worked intensively to set up experiments 
where patients and clinicians could collaborate remotely [1].  
We termed some of this work “bike-integration,” since every experiment involved 
personal agreement on date and time with many patients (~25), producing and mailing 
out information material, calling or visiting patients prior to the experiment as well as 
bicycling to the hospital on the day prior to the experiment to ensure the needed 
printouts were there for the clinicians to use during the experiment. A major reason for 
the overhead work in CITH was the increase in dependencies when trying out 
prototype features that connect different people, as well as the fact that we introduced 
new technology features that changed work practices and required introduction.  
In the SCAUT project, we have taken measures to mitigate overhead work since 
we need to scale up the number of participants involved in the prototype experiments. 
This primarily involves designing and building a software tool - an R&D engine - to 
support the coordination work related to the participatory prototyping process. 
Scaling up the number of participants is a means to increase the chances of 
delivering a product that meets users’ needs and thus holds market potentials. This 
introduces the need for making the process more efficient than earlier. For example, we 
need efficient ways to communicate with individuals and groups of patients. We need 
to be able to keep an overview of patients’ use and non-use of the different app features 
as well as simple ways to keep them interested and informed about progression of the 
project. We need to be able to communicate needs and requirements to developers so 
there will be a natural inflow of prototypes to be evaluated by end users. Inspired by for 
example customer-relation management systems, medical progress notes, and online 
video guides we are building a customized R&D tool that is tightly connected to the 
app- and web-prototypes. The purpose is to support a R&D process with fewer 
resources involved when experimenting with the prototypes. We will make it easy to 
introduce new features to many participants by providing in-app videos and by 
developing a message module. We aim to make use of in-app newsletters and create an 
idea-voting system as a way to involve many participants. We aim to make it easy to 
follow use and non-use by creating ‘use-scores’ and making it possible to easily keep 
track of individuals and groups of patients by elaborated personal profiles with 
information relevant to running the process. Here, we aim also to include indicators 
such as ‘take a look at’ or ‘contact patient’, which can be set manually or automatically.  
2.2. The Challenge of Integrating All Stakeholders’ Interests Up Front  
The methodological approach needs to take into account that the SCAUT project will 
deliver a commercial product. Instead, the purpose of the CITH project was to 
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 investigate opportunities and concepts, and progress was evaluated as the degree to 
which patients and clinicians found the developed concepts, features and affordances 
meaningful, actionable and organizationally feasible [2]. It was not part of the agenda 
to investigate the commercial potential in detail. However, in SCAUT the market plays 
a much more central role. The market interests are primarily taken care of by the 
software company and the device manufacturer. One of their natural concerns is the 
commercial potential of the prototypes. From a methodological point of view this 
means that we need to find ways to integrate also their interests in the transition from 
one prototype to the next. 
We propose three mitigation strategies for this. First, we advocate involving users 
more than is typical in commercial settings - and in additional roles. Patients and 
clinicians need to be involved not only for the purpose of testing or approving 
assumptions, but also for the purpose of exploring, experimenting and evaluating 
features and affordances of the evolving prototypes [3].  Second, we pre-assess the 
value propositions of the prototypes by using the Business Model Canvas [14], the 
results of which will feed into the third mitigation strategy: The Stage Gate Model. 
However, the latter is inscribed in a waterfall model in order to have “well defined 
gates”, and prototyping is not used until requirements are fixed. Therefor, and inspired 
by Scrum [16], we have adjusted The Stage Gate Model to include explorative and 
experimental prototyping up front. This will produce more relevant materials at the 
gates based on real users’ real experiences with evolving prototypes. 
2.3. The Challenge of Designing Within Regulatory Requirements 
To be able to bring an eHealth system (all the way) to the market, means that we have 
to ensure the system will meet regulatory requirements. Rather than postponingthis, we 
recommend engaging with the regulatory issues early in the process. Even though the 
system is solely software-based, it is considered a ‘medical device’ in regulatory terms 
[13] and will have to pass regulatory assessment and approval by the relevant 
authorities (e.g. FDA for the US market and EU MDD for the European). Many R&D 
endeavors postpone (or neglect to consider) the regulatory process, mostly because it is 
either too complicated early in the process or because the knowledge of what the 
product will be is too uncertain to begin structuring a regulatory process around it. 
However, although it might seem wise to hold off regulatory considerations until it 
is clear what the eHealth system actually consists of, this will almost inevitably result 
in a system that is nearly impossible to get approved. This is because some of the 
requirements have implications that extend all the way into how the fieldwork is 
conducted in order to enable proper documentation of user needs, and features to 
support those needs, later in the process. Other requirements have implications for 
whether the system ‘displays’ information (lower requirements) or rather transforms 
information (more strict requirements). The differences in those categories are 
monumental [13]. Hence, we argue to engage the requirements early on and work with 
them as ‘just’ another actor or constraint on the project. On way we do this in SCAUT 
is to modularize the software (architecture) to isolate and minimize the components that 
‘transform’ information. Another way is that when we sketch and mock-up features 
that are informed by the fieldwork, we carefully consider whether we can accomplish 
the same without transforming the information right away, or leave the transformation 
to later. In other words, we recommend that regulatory demands are treated as design 
parameters and seen as a resource for the project. The requirements should be dealt 
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 with early in the process and should not be postponed to the final stages. 
3. Concluding Remarks 
Based on reflections on two projects, we propose mitigation strategies to be considered 
when engaging in R&D of marketable eHealth systems. The strategies suggest how to 
establish an efficient R&D process in order to scale and evaluate the system with many 
patients, and how to integrate stakeholders’ interests early on in order to align 
commercial interest with those of patients and clinicians. Finally, we suggest how to 
consider regulatory demands and integrate them as design parameters for the project. 
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